CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Show more

300 Connell Drive, Berkeley Heights, NJ, 07922, United States

Biotechnology
Healthcare
Start AI Chat

Market Cap

552.3M

52 Wk Range

$5.60 - $17.43

Previous Close

$7.01

Open

$7.01

Volume

969,492

Day Range

$6.95 - $7.13

Enterprise Value

672.3M

Cash

55.72M

Avg Qtr Burn

N/A

Insider Ownership

8.15%

Institutional Own.

55.15%

Qtr Updated

09/30/25